AFT Pharmaceuticals Ltd: Update - Dividend/Distribution - AFP
AFT Pharmaceuticals Ltd: AFT to launch Maxigesic Rapid in the United States
AFT Pharmaceuticals Ltd: Annual Meeting and Closing Date for Director Nominations
AFT Pharmaceuticals Ltd: Dividend/Distribution - AFP
AFT Pharmaceuticals Ltd: Distribution notice
AFT Pharmaceuticals Ltd: AFT Licenses Maxigesic IV in Brazil
AFT Pharmaceuticals Ltd: AFT,Massey Ventures,Gilles McIndoe to develop scar treatment
AFT Pharmaceuticals Ltd: AFT makes further progress in international markets
AFT Pharmaceuticals Ltd: Maxigesic IV launched in the United States
AFT Pharmaceuticals Ltd: AFT further broadens R&D pipeline with new product candidate
AFT Pharmaceuticals Ltd: AFT broadens R&D pipeline with new product candidate
AFT Pharmaceuticals Ltd: AFT Crystaderm antiseptic approved for sale in China
AFT Pharmaceuticals Ltd: AFP welcomes US FDA approval for sale of Maxigesic IV
AFT Pharmaceuticals Ltd: AFP half year interim results on Thursday November 23 2023
AFT Pharmaceuticals Ltd: Disclosure of Directors and Senior Managers Relevant Interes
AFT Pharmaceuticals Ltd: AFT Orphan Pharmaceuticals judgment
AFT Pharmaceuticals Ltd: Chairs Address
AFT Pharmaceuticals Ltd: AFT signs new licensing agreement for ZENEO Midazolam
AFT Pharmaceuticals Ltd: AFT extends e-commerce presence into Amazon US
AFT Pharmaceuticals Ltd: Dividend/Distribution - AFP
No Data